Short Interest in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Increases By 21.1%

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) was the recipient of a large growth in short interest in February. As of February 13th, there was short interest totaling 781,872 shares, a growth of 21.1% from the January 29th total of 645,905 shares. Based on an average daily volume of 119,993 shares, the days-to-cover ratio is currently 6.5 days. Currently, 15.0% of the company’s stock are sold short. Currently, 15.0% of the company’s stock are sold short. Based on an average daily volume of 119,993 shares, the days-to-cover ratio is currently 6.5 days.

SPDR S&P Pharmaceuticals ETF Price Performance

XPH stock opened at $55.30 on Friday. The business’s 50-day moving average is $56.60 and its two-hundred day moving average is $52.32. The firm has a market capitalization of $287.56 million, a P/E ratio of 14.28 and a beta of 0.60. SPDR S&P Pharmaceuticals ETF has a 1 year low of $35.22 and a 1 year high of $58.84.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

Large investors have recently bought and sold shares of the business. Advisory Services Network LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth about $34,000. Team Financial Group LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth about $56,000. Kestra Advisory Services LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth approximately $151,000. Vista Investment Management purchased a new stake in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth approximately $223,000. Finally, Stephens Inc. AR acquired a new position in SPDR S&P Pharmaceuticals ETF in the fourth quarter valued at approximately $229,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.